Citation Impact
Citing Papers
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011
Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
2007
Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
2009
Cabozantinib in Progressive Medullary Thyroid Cancer
2013
Cancer statistics, 2022
2022 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma
2013
Cancer statistics, 2023
2023 Standout
Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
2010
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
2015
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Current approaches to medullary thyroid carcinoma, sporadic and familial
2006
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016
Circulating Thyrotropin Receptor mRNA as a Novel Marker of Thyroid Cancer
2010
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation
1999
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
2021
Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?
2012
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
1999
The Differentiation of Benign and Malignant Thyroid Nodules
2005
High Prevalence of RAS Mutations in RET -Negative Sporadic Medullary Thyroid Carcinomas
2011
Prognostic Factors in Well-Differentiated Follicular-Derived Carcinoma and Medullary Thyroid Carcinoma
2001
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients
2011
Thyroid cancer
2016 Standout
Genetic effects on gene expression across human tissues
2017 StandoutNature
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer
2015
Synchronous Metastatic Medullary and Papillary Thyroid Carcinomas in a Patient with Germline RET Mutation: Case Report, Molecular Analysis, and Implications for Pathogenesis
2010
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study
2001
A comprehensive map of molecular drug targets
2016 Standout
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
2010 Standout
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
Réintervention pour carcinome médullaire de la thyroïde : résultats à long terme
2001
Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAFV600E Mutational Status of 977 Cases
2013
HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules
2010
Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation
1999
Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma
2013
Peroxisome-proliferator-activated receptors and cancers: complex stories
2004
PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway
2005
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
2013
Medullary Thyroid Cancer
1995
Nomograms in oncology: more than meets the eye
2015 Standout
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
2013
Phaeochromocytoma
2005 Standout
The Genetic Basis of Pheochromocytoma
2003
Head and neck cancer
2008 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Mesenchymal stem cells in health and disease
2008 Standout
Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study
2011
Cellular Senescence in Cancer and Aging
2007 Standout
BRAF mutation in thyroid cancer
2005
American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery
2014
The biology and function of fibroblasts in cancer
2016 Standout
The Paired Box-8/Peroxisome Proliferator-Activated Receptor-γ Oncogene in Thyroid Tumorigenesis
2006
Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States
2013
Medullary Thyroid Carcinoma
2007
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
2013
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment
2012
Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicenter study
2013
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period
2004
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
2013
The first molecular details of ALT in human tumor cells
2005
A Founding Locus within the RET Proto-Oncogene May Account for a Large Proportion of Apparently Sporadic Hirschsprung Disease and a Subset of Cases of Sporadic Medullary Thyroid Carcinoma
2003
Somatic VHLgene alterations in MEN2-associated medullary thyroid carcinoma
2006
Germline Homozygous Mutations at Codon 804 in theRETProtooncogene in Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2A Patients
2005
Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer
2013
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
2000
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
2014
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
2007
A Novel Somatic Mutation in the RET Proto‐oncogene in Familial Medullary Thyroid Carcinoma with a Germline Codon 768 Mutation
1997
BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer
2012
Beyond the Suspicious Thyroid Fine Needle Aspirate
2003
An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma
2006
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.
2006
The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins
2007
Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES)
2013
Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma
2002
TheRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
1996
Formation of Arabidopsis Cryptochrome 2 Photobodies in Mammalian Nuclei
2013 StandoutNobel
BRAF mutations in papillary carcinomas of the thyroid
2003
Progress in molecular-based management of differentiated thyroid cancer
2013
Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence
2013
Multiple endocrine neoplasia type 2B — genetic basis and clinical expression
2000
Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
1997
The essence of senescence: Figure 1.
2010 Standout
Higher rate of BRAF mutation in papillary thyroid cancer over time
2011
Treatment of medullary thyroid carcinoma: an update.
2001
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
p53 in health and disease
2007 Standout
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns
2010
Long-term Results of Reoperation and Localizing Studies in Patients With Persistent or Recurrent Medullary Thyroid Cancer
2000
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
Alternative lengthening of telomeres: models, mechanisms and implications
2010
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma
2011
Loss of Heterozygosity at theRETProtooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A1
2001
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene
2008
Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer
2012
Prognostic value of codon 918 (ATG?ACG)RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
2001
Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?
2010
Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
2015
A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1
2015
Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer
2011
Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: Implications for therapy
1996
p44/p42-MAP kinase expression in papillary thyroid carcinomas
2001
Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients
1997
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype
2016
RET/PTC Rearrangement in Thyroid Tumors
2002
Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
2007
Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary
2001
<I>RET </I>Polymorphisms and Sporadic Medullary Thyroid Carcinoma in a Portuguese Population
2005
A census of human cancer genes
2004 Standout
Changing patterns of thyroid carcinoma
2007
Molecular genetics and diagnosis of thyroid cancer
2011
Medullary thyroid carcinoma
2000
Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance
2005
The surgical treatment of medullary thyroid carcinoma
1999
Incidental Papillary Microcarcinoma of the Thyroid—Further Evidence of a Very Low Malignant Potential: A Retrospective Clinicopathological Study With Up to 30 Years of Follow-Up
2011
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
p53 and disease: when the guardian angel fails
2006
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Tumours of familial origin in the head and neck
2006
Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre
2006
Multiple endocrine neoplasia type 2 RET protooncogene database: Repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations
2009
Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis
2000
Clinical, Safety, and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review
2013
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Thyroid Carcinomas Involving Follicular and Parafollicular C Cells: Seventeen Cases with Characterization of RET Oncogenic Activation
2004
Poorly Differentiated Follicular Thyroid Carcinoma: Prognostic Factors and Relevance of Histological Classification
2007
A Systematic Review and Meta-Analysis of Prophylactic Central Neck Dissection on Short-Term Locoregional Recurrence in Papillary Thyroid Carcinoma After Total Thyroidectomy
2013
The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012
2015
BRAF : A Tool in the Decision to Perform Elective Neck Dissection?
2012
Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases
2001
The Role of Radiotherapy in the Management of Elevated Calcitonin After Surgery for Medullary Thyroid Cancer
2001
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care
2013
Papillary Thyroid Carcinoma in Patients with RET Proto-Oncogene Germline Mutation
2002
Frequency and Relevance of Elevated Calcitonin Levels in Patients with Neoplastic and Nonneoplastic Thyroid Disease and in Healthy Subjects
2004
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
2016 StandoutNobel
Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: A retrospective study of 109 consecutive patients
1996
Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
2004
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
1999 Standout
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Prospective Trial of Unilateral Surgery for Nonhereditary Medullary Thyroid Carcinoma in Patients without Germline RET Mutations
2002
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Medullary Thyroid Carcinoma
1998
Genotype‐Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma
2007
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
1997
Peroxisome Proliferator-Activated Receptor γ Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
2008
Cancer statistics in China, 2015
2016 Standout
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
A Novel Activating Mutation in the RET Tyrosine Kinase Domain Mediates Neoplastic Transformation
2006
Diabetes and Cancer
2010 Standout
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain
1999
Clinical and Genetic Experience in Turkish Multiple Endocrine Neoplasia Type 2 Families
2007
Medullary thyroid cancer diagnosis: An appraisal
2013
Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment
2011
Papillary Thyroid Microcarcinoma: Extrathyroidal Extension, Lymph Node Metastases, and Risk Factors for Recurrence in a High Prevalence of Goiter Area
2010
Thyroid Disorders of Pregnancy
1995
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-termIn vitroCulture and Do Not Exhibit Telomere Maintenance Mechanisms
2007
A global view on cancer incidence and national levels of the human development index
2016
Approach to the Thyroid Cancer Patient with Bone Metastases
2011
Cancer Genome Landscapes
2013 StandoutScience
Prophylactic central neck dissection for papillary thyroid cancer
2012
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
2002
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
2014
Diversity of mutations in theRETproto-oncogene and its oncogenic mechanism in medullary thyroid cancer
2015
Guidelines for the management of thyroid cancer
2014 Standout
BRAFV600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
2012
RET Proto-Oncogene in the Development of Human Cancer
1999
Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma
1998
Medullary thyroid carcinoma: a review on ethical considerations in treatment of children
2016
EMT, CTCs and CSCs in tumor relapse and drug-resistance
2015
Increasing thyroid cancer incidence in Q ueensland, A ustralia 1982–2008 – true increase or overdiagnosis?
2015
Evaluation of Gender Inequity in Thyroid Cancer Diagnosis
2021
Thyroid carcinoma
2003 Standout
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
2013
Works of Diana Learoyd being referenced
Genetic Testing for Familial Cancer
1997
Medullary Thyroid Carcinoma: Recent Advances and Management Update
1995
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
2011
Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma
1998
The practical management of multiple endocrine neoplasia
1995
Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas
2003
Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma
1996
RET/PTCandRETTyrosine Kinase Expression in Adult Papillary Thyroid Carcinomas1
1998
Adrenal incidentalomas: Risk of adrenocortical carcinoma and clinical outcomes
2010
Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma
2012
Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment
2010
Increasing incidence of thyroid cancer is due to increased pathologic detection
2008
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations
2005
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism
2002
Postpartum Thyroid Dysfunction
1992
NEW ERA: PROPHYLACTIC SURGERY FOR PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA‐2A
2006
A Preoperative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer
2013
PAX8-Peroxisome Proliferator-Activated Receptor γ (PPARγ) Disrupts Normal PAX8 or PPARγ Transcriptional Function and Stimulates Follicular Thyroid Cell Growth
2005
Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors
1997
Patterns of Structural Recurrence in Papillary Thyroid Cancer
2013
Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome
2001
A Robust Assay for Alternative Lengthening of Telomeres in Tumors Shows the Significance of Alternative Lengthening of Telomeres in Sarcomas and Astrocytomas
2005
Molecular Genetics of Thyroid Tumors and Surgical Decision‐making
2000
Glucocorticoids differentially inhibit expression of the RET proto-oncogene.
1999
Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
1996
Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer
2010
BRAFV600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer
2010
Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion
2010
Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
1997
Surgical approach to medullary thyroid cancer
2007
Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer
2012